U.S. markets open in 36 minutes
  • S&P Futures

    3,818.50
    +1.75 (+0.05%)
     
  • Dow Futures

    31,299.00
    +63.00 (+0.20%)
     
  • Nasdaq Futures

    12,691.25
    +9.50 (+0.07%)
     
  • Russell 2000 Futures

    2,206.50
    +0.70 (+0.03%)
     
  • Crude Oil

    62.44
    +1.16 (+1.89%)
     
  • Gold

    1,714.20
    -1.60 (-0.09%)
     
  • Silver

    26.15
    -0.24 (-0.90%)
     
  • EUR/USD

    1.2037
    -0.0031 (-0.25%)
     
  • 10-Yr Bond

    1.4770
    +0.0070 (+0.48%)
     
  • Vix

    26.24
    +2.14 (+8.88%)
     
  • GBP/USD

    1.3967
    +0.0015 (+0.11%)
     
  • USD/JPY

    107.4500
    +0.4480 (+0.42%)
     
  • BTC-USD

    49,576.89
    -2,730.47 (-5.22%)
     
  • CMC Crypto 200

    993.33
    +6.12 (+0.62%)
     
  • FTSE 100

    6,648.58
    -26.89 (-0.40%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

InMode to Present at the 23rd Annual Needham Growth Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

YOKNEAM, Israel, Jan. 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, and Mr. Yair Malca, Chief Financial Officer will present virtually at the 23rd Annual Needham Growth Conference on Thursday, January 14, 2021 at 8:30 am EST.

InMode Logo (PRNewsfoto/InMode)
InMode Logo (PRNewsfoto/InMode)

To schedule a meeting please contact your Needham salesperson or Miri Segal at ir@inmodemd.com.

A live webcast of the presentations will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentation.

About InMode

InMode (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.

For more information about InMode, please visit www.inmodemd.com.

Logo - https://media.zenfs.com/en/prnewswire.com/17ff7d9be06fd4e26341ab1fffd77ad4

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
+1-917-607-8654

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/inmode-to-present-at-the-23rd-annual-needham-growth-conference-301200415.html

SOURCE InMode Ltd.